Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site.
about
Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors.2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity.Third generation EGFR TKIs: current data and future directions.C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?
P2860
Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Trisubstituted Pyridinylimidaz ...... nd the Phosphate Binding Site.
@en
type
label
Trisubstituted Pyridinylimidaz ...... nd the Phosphate Binding Site.
@en
prefLabel
Trisubstituted Pyridinylimidaz ...... nd the Phosphate Binding Site.
@en
P2093
P50
P1476
Trisubstituted Pyridinylimidaz ...... and the Phosphate Binding Site
@en
P2093
Eva Döring
Hannah L Tumbrink
Julian Engel
Marcel Günther
Marina Keul
Michael Juchum
P304
P356
10.1021/ACS.JMEDCHEM.7B00316
P407
P577
2017-06-21T00:00:00Z